Lyra Therapeutics (LYRA) Treasury Shares (2019 - 2025)
Lyra Therapeutics (LYRA) recorded quarterly Treasury Shares of $51814.0 in Q4 2025, down 12.0% on a QoQ basis from $58882.0 in Q3 2025, and up 20.88% YoY from $42865.0 in Q4 2024.
Lyra Therapeutics (LYRA) Treasury Shares (2019 - 2025) Analysis & Trends
Lyra Therapeutics (LYRA) has reported Treasury Shares for 6 consecutive years, with $51814.0 the latest figure, recorded in Q4 2025.
- Treasury Shares for Q4 2025 came in at $51814.0, up 20.88% year-over-year; the trailing twelve-month figure through Dec 2025 was $51814.0 (up 20.88% YoY), and the FY2025 annual result was $51814.0, up 20.88% from the prior year.
- Treasury Shares for Q4 2025 stood at $51814.0, down from $58882.0 in the prior quarter.
- The five-year high for Treasury Shares was $4.7 million in Q1 2025, with the low at $28212.0 in Q4 2022.
- A 4-year average of $548418.8 and a median of $95426.0 in 2023 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares surged 588.08% in 2023 and sank 93.21% in 2025, its largest moves.
- Lyra Therapeutics' Treasury Shares stood at $28212.0 in 2022, then soared by 272.35% to $105048.0 in 2023, then slumped by 59.19% to $42865.0 in 2024, then rose by 20.88% to $51814.0 in 2025.
- The last three Treasury Shares figures came in at $51814.0 (Q4 2025), $58882.0 (Q3 2025), and $85804.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Lyra Therapeutics | 70,995.28 | 70,995.28 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 51,814.00 |
| Dec 31, 2025 | 51,814.00 |
| Sep 30, 2025 | 58,882.00 |
| Sep 30, 2025 | 58,882.00 |
| Jun 30, 2025 | 85,804.00 |
| Jun 30, 2025 | 85,804.00 |
| Mar 31, 2025 | 4.74 Mn |
| Mar 31, 2025 | 4.74 Mn |
| Dec 31, 2024 | 42,865.00 |
| Dec 31, 2024 | 42,865.00 |
| Sep 30, 2024 | 867,472.00 |
| Sep 30, 2024 | 867,472.00 |
| Jun 30, 2024 | 867,472.00 |
| Jun 30, 2024 | 867,472.00 |
| Mar 31, 2024 | 1.06 Mn |
| Mar 31, 2024 | 1.06 Mn |
| Dec 31, 2023 | 105,048.00 |
| Dec 31, 2023 | 105,048.00 |
| Sep 30, 2023 | 243,703.00 |
| Sep 30, 2023 | 243,703.00 |